Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Hims & Hers Health (HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS

$HIMSPress releaseSep 8, 2026, 6:41 PM ETRead the release

Hims & Hers Health faces a securities class action and an FTC complaint alleging serious business misconduct and privacy violations. The lawsuit alleges the company shared sensitive health data with third-party advertising platforms and enrolled consumers in subscription models without informed consent, violating the Restore Online Shoppers' Confidence Act.

Key figures

Deal Value Usd
970000000
Share price drop pct
-14.7

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    HIMS: Hims & Hers Health (HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS — AI Analysis | Signal8